ISSN : 2663-2187

A Cross-sectional study to evaluate aspartae platelet ratio index (APRI) as a non-invasive and cost effective predictor for the diagnosis of liver fibrosis and esophageal varices in chronic liver disease patients in a tertiary care center in south Indi

Main Article Content

Dr. Rahees E.K, Prof. Dr. V.R Mohan Rao, Dr.V.M.Jyostna Grace, Dr P.Tamilselvi, 5Dr.Yaramaneni Nageswara Rao
» doi: 10.48047/AFJBS.6.14.2024.4160-4191

Abstract

Background and Aim Fibrotic stage (FS) assessment is essential in chronic hepatitis C treatment cascade. Liver stiffness measurement (LSM) using transient elastography (TE) is reliable and correlated with liver biopsy. However, TE may not be widely available. This study aimed to evaluate the diagnostic performances of aspartate aminotransferase to platelet ratio index (APRI) and fibrosis 4 (FIB‐4) scores compared with TE. Methods We conducted a cross‐sectional study, including all chronic hepatitis C virus (HCV) monoinfection patients with successful and reliable LSM at Chettinad institue Kelambakkam. Characteristics and laboratory data within 3 months of TE were retrospectively reviewed. Using TE as a reference standard, the diagnostic performances of APRI and FIB‐4 were evaluated. TE cut‐off levels of 7.1 and 12.5 kPa represented significant fibrosis (SF) and cirrhosis, respectively

Article Details